Resolution of severe peristomal pyoderma gangrenosum with infliximab in a child with Crohn disease

J Pediatr Gastroenterol Nutr. 2002 May;34(5):558-60. doi: 10.1097/00005176-200205000-00016.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal / therapeutic use*
  • Crohn Disease / complications*
  • Dermatologic Agents / administration & dosage
  • Dermatologic Agents / therapeutic use*
  • Female
  • Humans
  • Infliximab
  • Pyoderma Gangrenosum / drug therapy*
  • Pyoderma Gangrenosum / etiology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Dermatologic Agents
  • Infliximab